Chenyang Qiao

815 total citations · 1 hit paper
19 papers, 618 citations indexed

About

Chenyang Qiao is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Epidemiology. According to data from OpenAlex, Chenyang Qiao has authored 19 papers receiving a total of 618 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 5 papers in Pathology and Forensic Medicine and 5 papers in Epidemiology. Recurrent topics in Chenyang Qiao's work include Liver Disease Diagnosis and Treatment (5 papers), Cancer Mechanisms and Therapy (4 papers) and Circular RNAs in diseases (3 papers). Chenyang Qiao is often cited by papers focused on Liver Disease Diagnosis and Treatment (5 papers), Cancer Mechanisms and Therapy (4 papers) and Circular RNAs in diseases (3 papers). Chenyang Qiao collaborates with scholars based in China. Chenyang Qiao's co-authors include Xiaoke Zhang, Lei Ge, Xiqun Jiang, Kaichun Wu, Limin Xia, Yongzhan Nie, Weibo Feng, Daiming Fan, Jie Chen and Dean Tian and has published in prestigious journals such as Nano Letters, Hepatology and Oncogene.

In The Last Decade

Chenyang Qiao

16 papers receiving 616 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Light-Activated Hypoxia-Sensitive Covalent Organic Framework for Tandem-Responsive Drug Delivery

2021 232 citations Lei Ge, Chenyang Qiao et al. Nano Letters profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Chenyang Qiao China	11	271	204	174	133	101	19	618
Hongjun Yuan China	15	220 0.8×	145 0.7×	171 1.0×	365 2.7×	141 1.4×	34	818
Qianhui Xu China	12	308 1.1×	231 1.1×	195 1.1×	256 1.9×	139 1.4×	21	744
Oh‐Joon Kwon United States	14	297 1.1×	130 0.6×	113 0.6×	83 0.6×	162 1.6×	23	744
Zhongqian Hu China	17	294 1.1×	159 0.8×	164 0.9×	494 3.7×	64 0.6×	31	839
Tiancong Shi China	8	128 0.5×	79 0.4×	213 1.2×	294 2.2×	101 1.0×	17	572
Fuli Xin China	10	103 0.4×	123 0.6×	107 0.6×	268 2.0×	116 1.1×	23	548
Qiongchao Jiang China	11	103 0.4×	52 0.3×	90 0.5×	134 1.0×	70 0.7×	18	441
Shangzhi Xie China	14	565 2.1×	361 1.8×	74 0.4×	178 1.3×	188 1.9×	33	925
Peipei Dai China	7	216 0.8×	148 0.7×	229 1.3×	529 4.0×	54 0.5×	8	722
Guanhua Qiu China	11	177 0.7×	74 0.4×	135 0.8×	306 2.3×	58 0.6×	31	547

Countries citing papers authored by Chenyang Qiao

Since Specialization

Citations

This map shows the geographic impact of Chenyang Qiao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chenyang Qiao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chenyang Qiao more than expected).

Fields of papers citing papers by Chenyang Qiao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chenyang Qiao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chenyang Qiao. The network helps show where Chenyang Qiao may publish in the future.

Co-authorship network of co-authors of Chenyang Qiao

This figure shows the co-authorship network connecting the top 25 collaborators of Chenyang Qiao. A scholar is included among the top collaborators of Chenyang Qiao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chenyang Qiao. Chenyang Qiao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Qiao, Chenyang, et al.. (2025). Association of Inflammatory Factors and Calcium Metabolism With Arthritis in Patients With Inflammatory Bowel Disease: Evidence From Mediated Mendelian Randomization. Mediators of Inflammation. 2025(1). 1675577–1675577.

Tantai, Xinxing, et al.. (2024). Low muscle quality index is associated with increased risk of advanced fibrosis in adult patients with nonalcoholic fatty liver disease: NHANES 2011–2014. Scientific Reports. 14(1). 19883–19883.

Wang, Lumin, Chenyang Qiao, Lili Han, et al.. (2024). HOXD3 promotes the migration and angiogenesis of hepatocellular carcinoma via modifying hepatocellular carcinoma cells exosome-delivered CCR6 and regulating chromatin conformation of CCL20. Cell Death and Disease. 15(3). 221–221. 8 indexed citations

Sha, Sumei, Bin Xu, Chenyang Qiao, et al.. (2024). Case report: Successful remission with upadacitinib in a young patient with anti-TNF-refractory intestinal Behçet’s disease. Frontiers in Immunology. 15. 1483993–1483993. 3 indexed citations

Wang, Lumin, Chenyang Qiao, Li Cao, et al.. (2022). Significance of HOXD transcription factors family in progression, migration and angiogenesis of cancer. Critical Reviews in Oncology/Hematology. 179. 103809–103809. 12 indexed citations

Feng, Weibo, et al.. (2022). [T cell factor 3 (TCF3) is overexpressed in hepatocellular carcinoma and promotes their invasion and metastasis].. PubMed. 38(1). 66–73.

Li, Yan, Lu Qiao, Cailan Xiao, et al.. (2021). Identification of SRGAP2 as a potential oncogene and a prognostic biomarker in hepatocellular carcinoma. Life Sciences. 277. 119592–119592. 10 indexed citations

Qiao, Chenyang, Wenjie Huang, Jie Chen, et al.. (2021). IGF1-mediated HOXA13 overexpression promotes colorectal cancer metastasis through upregulating ACLY and IGF1R. Cell Death and Disease. 12(6). 564–564. 46 indexed citations

Ge, Lei, et al.. (2021). Light-Activated Hypoxia-Sensitive Covalent Organic Framework for Tandem-Responsive Drug Delivery. Nano Letters. 21(7). 3218–3224. 232 indexed citations breakdown →

10.

Chen, Jie, Yunzhi Dang, Weibo Feng, et al.. (2021). Correction: SOX18 promotes gastric cancer metastasis through transactivating MCAM and CCL7. Oncogene. 40(24). 4242–4243. 1 indexed citations

11.

Feng, Weibo, Wenjie Huang, Jie Chen, et al.. (2021). CXCL12-mediated HOXB5 overexpression facilitates Colorectal Cancer metastasis through transactivating CXCR4 and ITGB3. Theranostics. 11(6). 2612–2633. 50 indexed citations

12.

Chen, Jie, Yunzhi Dang, Weibo Feng, et al.. (2020). SOX18 promotes gastric cancer metastasis through transactivating MCAM and CCL7. Oncogene. 39(33). 5536–5552. 30 indexed citations

13.

Du, Feng, Xiaowei Li, Weibo Feng, et al.. (2020). SOX13 promotes colorectal cancer metastasis by transactivating SNAI2 and c-MET. Oncogene. 39(17). 3522–3540. 40 indexed citations

14.

Dang, Yunzhi, Jie Chen, Weibo Feng, et al.. (2020). Interleukin 1β-mediated HOXC10 Overexpression Promotes Hepatocellular Carcinoma Metastasis by Upregulating PDPK1 and VASP. Theranostics. 10(8). 3833–3848. 45 indexed citations

15.

Du, Feng, Chenyang Qiao, Xiaowei Li, et al.. (2019). Forkhead box K2 promotes human colorectal cancer metastasis by upregulating ZEB1 and EGFR. Theranostics. 9(13). 3879–3902. 38 indexed citations

16.

Chen, Jie, Feng Du, Yunzhi Dang, et al.. (2019). Fibroblast Growth Factor 19–Mediated Up‐regulation of SYR‐Related High‐Mobility Group Box 18 Promotes Hepatocellular Carcinoma Metastasis by Transactivating Fibroblast Growth Factor Receptor 4 and Fms‐Related Tyrosine Kinase 4. Hepatology. 71(5). 1712–1731. 42 indexed citations

17.

Li, Feng, et al.. (2018). Circulating cell-free DNA of methylated insulin-like growth factor-binding protein 7 predicts a poor prognosis in hepatitis B virus-associated hepatocellular carcinoma after hepatectomy. Free Radical Research. 52(4). 455–464. 27 indexed citations

18.

Qiao, Chenyang, Feng Li, Yue Teng, et al.. (2017). Aberrant GSTP1 promoter methylation predicts poor prognosis of acute-on-chronic hepatitis B pre-liver failure. Clinical and Experimental Medicine. 18(1). 51–62. 9 indexed citations

19.

Hu, Na, et al.. (2017). Hypomethylated Ubiquitin-Conjugating Enzyme2 Q1 (UBE2Q1) Gene Promoter in the Serum Is a Promising Biomarker for Hepatitis B Virus-Associated Hepatocellular Carcinoma. The Tohoku Journal of Experimental Medicine. 242(2). 93–100. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact